Effect of Hypertension on Long-term Adverse Clinical Outcomes and Liver Fibrosis Progression in MASLD.
Zhou XD, Lian L, Chen QF, Kim SU, Cheuk-Fung Yip T, Petta S, Nakajima A, Tsochatzis E, Shi J, Chan WK, Boursier J, Bugianesi E, Yilmaz Y, Hagström H, Romero-Gomez M, Alswat K, Calleja JL, Takahashi H, de Lédinghen V, Shalimar, Castéra L, Sanyal AJ, Boon-Bee Goh G, Newsome PN, Fan JG, Lai M, Aggarwal S, Kechagias S, Hiasa Y, Dayal B, Zhang Z, George J, El-Kassas M, Chen J, You H, Abu Dayyeh BK, Sheng H, Adams LA, Wang J, He F, Liang H, Yang YF, Chi X, Zhong B, Bi Y, Mi Y, Zhu Y, Bai R, Zhang J, Wang B, Song J, Deng H, Xie Q, Bai L, Xin Y, Xie W, Li J, Fournier-Poizat C, Zoncapè M, Xia T, Ju S, Wu C, Lee HW, Lai-Hung Wong G, Armandi A, Shang Y, Pennisi G, Llop E, Yoneda M, de Saint-Loup M, Canivet CM, Lara-Romero C, Gallego-Durán R, Fernández PC, Asgharpour A, Kim-Jun Teh K, Mahgoub S, Sau-Wai Chan M, Lin H, Liu WY, Song SJ, Al-Hamoudi WK, Isoda H, Miyake T, Satapathy SK, Li M, Sharma K, Emadeldeen M, Zhou L, Tong X, Bazerbachi F, Fan X, Xiao H, Ye J, Xu L, Wang X, Targher G, Byrne CD, Shapiro MD, Tacke F, Wai-Sun Wong V, Zheng MH; VCTE-Prognosis Study Group and Paired Liver Biopsy Consortium.
Zhou XD, et al.
J Hepatol. 2025 Aug 23:S0168-8278(25)02453-5. doi: 10.1016/j.jhep.2025.08.017. Online ahead of print.
J Hepatol. 2025.
PMID: 40854336